Anthem Biosciences Ltd

ANTHEM

Company Profile

  • Business description

    Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.

  • Contact

    No. 49, F1 & F2, Canara Bank Road
    Bommasandra Industrial Area, Phase 1
    Bommasandra
    BangaloreKA560 099
    IND

    T: +91 8066724000

    https://www.anthembio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2027

    Employees

Stocks News & Analysis

stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks

ASX energy share remains cheap despite strong outlook

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,938.7010.70-0.12%
CAC 408,141.9215.90-0.19%
DAX 4024,083.5345.45-0.19%
Dow JONES (US)49,167.7962.92-0.13%
FTSE 10010,321.0957.99-0.56%
HKSE25,925.6552.42-0.20%
NASDAQ24,887.1050.500.20%
Nikkei 22560,194.74342.62-0.57%
NZX 50 Index12,754.66120.28-0.93%
S&P 5007,173.918.830.12%
S&P/ASX 2008,710.8010.40-0.12%
SSE Composite Index4,086.140.20-0.00%

Market Movers